Weichselbaum RR - Search Results

1

Radioimmunoscintigraphy for postprostatectomy radiotherapy: analysis of toxicity and biochemical control.

Jani AB, Blend MJ, Hamilton R, Brendler C, Pelizzari C, Krauz L, Sapra B, Vijayakumar S, Awan A, Weichselbaum RR. Jani AB, et al. Among authors: weichselbaum rr. J Nucl Med. 2004 Aug;45(8):1315-22. J Nucl Med. 2004. PMID: 15299055 Free article.

2

Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.

Vijayakumar S, Karrison T, Weichselbaum RR, Chan S, Quadri SF, Awan AM. Vijayakumar S, et al. Among authors: weichselbaum rr. Cancer Epidemiol Biomarkers Prev. 1992 Nov-Dec;1(7):541-5. Cancer Epidemiol Biomarkers Prev. 1992. PMID: 1284591

3

Treatment and prognosis of orbital non-Hodgkin's lymphomas.

Platanias LC, Putterman AM, Vijayakumar S, Recant W, Weichselbaum RR, Bitran JD. Platanias LC, et al. Among authors: weichselbaum rr. Am J Clin Oncol. 1992 Feb;15(1):79-83. doi: 10.1097/00000421-199202000-00015. Am J Clin Oncol. 1992. PMID: 1372464

4

Prognostic indicators in node-negative early stage breast cancer.

Wong WW, Vijayakumar S, Weichselbaum RR. Wong WW, et al. Among authors: weichselbaum rr. Am J Med. 1992 May;92(5):539-48. doi: 10.1016/0002-9343(92)90751-v. Am J Med. 1992. PMID: 1580300 Review.

5

Palliative radiotherapy.

Awan AM, Weichselbaum RR. Awan AM, et al. Among authors: weichselbaum rr. Hematol Oncol Clin North Am. 1990 Dec;4(6):1169-81. Hematol Oncol Clin North Am. 1990. PMID: 1704880 Review.

6

Recent advances in radiation therapy for head and neck cancer.

Awan AM, Vokes EE, Weichselbaum RR. Awan AM, et al. Among authors: weichselbaum rr. Hematol Oncol Clin North Am. 1991 Aug;5(4):635-55. Hematol Oncol Clin North Am. 1991. PMID: 1890057 Review.

7

Radiotherapy with concomitant chemotherapy for head and neck cancer.

Vokes EE, Awan AM, Weichselbaum RR. Vokes EE, et al. Among authors: weichselbaum rr. Hematol Oncol Clin North Am. 1991 Aug;5(4):753-67. Hematol Oncol Clin North Am. 1991. PMID: 1890065 Review.

8

Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report).

Farah R, Chodak GW, Vogelzang NJ, Awan AM, Quiet CA, Moormeier J, Schoenberg H, Weichselbaum RR. Farah R, et al. Among authors: weichselbaum rr. Int J Radiat Oncol Biol Phys. 1991 Mar;20(3):413-7. doi: 10.1016/0360-3016(91)90050-e. Int J Radiat Oncol Biol Phys. 1991. PMID: 1995525 Clinical Trial.

9

Estimates of dose to intraperitoneal micrometastases from alpha and beta emitters in radioimmunotherapy.

Rotmensch J, Roeske J, Chen G, Pelizzari C, Montag A, Weichselbaum R, Herbst AL. Rotmensch J, et al. Gynecol Oncol. 1990 Sep;38(3):478-85. doi: 10.1016/0090-8258(90)90095-3. Gynecol Oncol. 1990. PMID: 2227565

10

Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters.

Roeske JC, Chen GT, Atcher RW, Pelizzari CA, Rotmensch J, Haraf D, Montag A, Weichselbaum RR. Roeske JC, et al. Among authors: weichselbaum rr. Int J Radiat Oncol Biol Phys. 1990 Dec;19(6):1539-48. doi: 10.1016/0360-3016(90)90370-y. Int J Radiat Oncol Biol Phys. 1990. PMID: 2262379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

802 results

Search Page

Filters